title: Blocking HMGB1 signal pathway protects early radiation-induced lung injury.
abstract: It has been reported that HMGB1 participated in various types of lung injury. In this study, we explored whether blocking HMGB1 has a preventive effect on the early radiation-induced lung injury and investigate the mechanism. Mice model of radiation-induced lung injury were accomplished by a single dose irradiation (15 Gy) to the whole thorax. Irradiated mice were treated with HMGB1-neutralizing antibody intraperitoneally dosed 10 μg, 50 μg, 100 μg/mouse respectively and were sacrificed after one week post-irradiation. Lung tissue slices were stained by H&E, and alveolitis was quantified by Szapiel scoring system. The level of cytokines TNF-γ in bronchoalveolar lavage fluid was detected by ELISA method. And p65NF-κB, p50NF-κB protein expression in mice lung tissues was detected by Western blot analysis. The results showed that blocking HMGB1 inhibited the inflammatory response, and thereby decreased the degree of alveolitis of irradiated lung tissue. In addition, HMGB1 antagonist can restrain the expression of type Th2 or Th17 derived inflammatory cytokines TNF-α, IL-6 and IL-17A, promote the expression of Th1 type cytokines INF-γ, and inhibit p65 NF-κB but promote p50 NF-κB activation, which promoted the resolution of the radiation-induced inflammatory response. In conclusion, blocking HMGB1 can reduce the degree of early radiation-induced lung injury, and its mechanism may be related to the promotion of p50NF-κB activation and its downstream molecules expression. Inhibiting HMGB1 may be a new target to deal with early radiation-induced lung injury.
authors.affiliation: Department of Cadre Health, Liaocheng People's Hospital Liaocheng, China.
authors.forename: Liping
authors.initials: L
authors.lastname: Wang
authors.affiliation: Department of Oncology, Liaocheng People's Hospital Liaocheng, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Zhang
authors.affiliation: Department of Oncology, Liaocheng People's Hospital Liaocheng, China.
authors.forename: Baozhong
authors.initials: B
authors.lastname: Wang
authors.affiliation: Department of Oncology, Liaocheng People's Hospital Liaocheng, China.
authors.forename: Guifu
authors.initials: G
authors.lastname: Wang
authors.affiliation: Department of Pathology, Liaocheng People's Hospital Liaocheng, China.
authors.forename: Junlong
authors.initials: J
authors.lastname: Xu
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000494:pharmacology; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D016207:Cytokines / Q000032:analysis; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D024243:HMGB1 Protein / Q000276:immunology* / Q000378:metabolism; D055370:Lung Injury / Q000378:metabolism / Q000517:prevention & control*; D051379:Mice; D020011:Protective Agents / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D057134:Antibodies, Neutralizing; D016207:Cytokines; D024243:HMGB1 Protein; D020011:Protective Agents; D014409:Tumor Necrosis Factor-alpha
keywords: HMGB1; NF-κB; radiation-induced lung injury